Inogen (INGN) Research & Development (2013 - 2026)
Inogen's (INGN) quarterly Research & Development came in at $24.6 million in Q1 2026, up 509.89% year-on-year from $4.0 million in Q1 2025, and down 70.57% on a QoQ basis from $83.6 million in Q4 2025.
Inogen (INGN) Research & Development (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Research & Development data on file, last reported at $24.6 million in Q1 2026.
- On a quarterly basis, Research & Development rose 509.89% year-over-year to $24.6 million in Q1 2026; TTM through Mar 2026 was $159.0 million, a 460.34% increase from a year earlier, with the FY2025 full-year figure at $97.7 million, up 352.07% from the prior year.
- Research & Development for Q1 2026 stood at $24.6 million, down from $83.6 million in the prior quarter.
- Over the last five years, Research & Development for INGN reached as high as $83.6 million in Q4 2025 and fell as low as -$70.2 million in Q4 2022.
- Historically, Research & Development has averaged $7.7 million across 5 years, with a median of $5.6 million in 2024.
- Across the five-year window, Research & Development tumbled 953.5% in 2024 and soared 623.11% in 2025, its largest moves.
- Year by year, Research & Development stood at -$70.2 million in 2022, then jumped by 109.56% to $6.7 million in 2023, then tumbled by 953.5% to -$57.3 million in 2024, then surged by 245.9% to $83.6 million in 2025, then tumbled by 70.57% to $24.6 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $24.6 million in Q1 2026, $83.6 million in Q4 2025, and $25.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 24.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.60 Mn |
| Dec 31, 2025 | 83.61 Mn |
| Sep 30, 2025 | 25.44 Mn |
| Jun 30, 2025 | 25.39 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | -57.30 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 26.94 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 4.49 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | -70.22 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 6.06 Mn |
| Mar 31, 2022 | 28.04 Mn |
| Dec 31, 2021 | -66.53 Mn |
| Sep 30, 2021 | 3.75 Mn |
| Jun 30, 2021 | 29.32 Mn |